AstraZeneca Decides It's OK to Make Money From the Pandemic
AstraZeneca (NASDAQ: AZN) has announced that it will begin selling its COVID-19 vaccine for a profit, after having pledged not to do so while the pandemic was still ongoing. In this Motley Fool Live video recorded on November 15, Motley Fool contributors Keith Speights and Brian Orelli discuss the company's plan for a "progressive transition" to the for-profit vaccine model and its likely strategy of raising vaccine prices notably only for wealthy countries.
Source Fool.com
